In some patients who completed a five-day course of Paxlovid, illness has been reported to reoccur between two and eight days after initial recovery from COVID-19. It’s characterized by a recurrence of symptoms or a new positive viral test after having tested negative. A brief return of symptoms may be part of the natural history of the virus in some patients, independent of Paxlovid treatment and regardless of vaccination status, according to the alert.
The agency said limited information is currently available from case reports on rebound COVID-19. There is currently no evidence that additional treatment is needed with Paxlovid or other therapies in cases where rebound is suspected.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
